Title: FDA's role in the evaluation of Avandia's safety
Subtitle: hearing before the Committee on Oversight and Government Reform, House of Representatives, One Hundred Tenth Congress, first session, June 6, 2007.
Subjects: United States, United States. Food and Drug Administration, Rosiglitazone, Side effects, Drugs, Chemotherapy, Testing, Diabetes
Places: United States